Sue Chua

High-Level Clonal <i>FGFR</i> Amplification and Response to FGFR Inhibition in a Translational Clinical Trial

Alex Pearson, Elizabeth Smyth, Irina S. Babina et al. · Cancer Discovery · 2016 · 276 citations · Full text

Medicine, Cancer Biology, Oncology +17

Non–Small Cell Lung Cancer Treated with Erlotinib: Heterogeneity of¹⁸F-FDG Uptake at PET—Association with Treatment Response and Prognosis

Gary Cook, Mary O’Brien, Muhammad Siddique et al. · Radiology · 2015 · 155 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Incidence, pattern and timing of brain metastases among patients with advanced breast cancer treated with trastuzumab

Thomas Yau, Charles Swanton, Sue Chua et al. · Acta Oncologica · 2006 · 141 citations · Full text

Medicine, Neurology, Oncology +14

89Zr-trastuzumab and 89Zr-bevacizumab PET to Evaluate the Effect of the HSP90 Inhibitor NVP-AUY922 in Metastatic Breast Cancer Patients

Sietske B.M. Gaykema, Carolien P. Schröder, Joanna Vitfell-Rasmussen et al. · Clinical Cancer Research · 2014 · 118 citations

Medicine, Oncology, Pharmacology +16

The potential of 223Ra and 18F-fluoride imaging to predict bone lesion response to treatment with 223Ra-dichloride in castration-resistant prostate cancer

Iain Murray, Sarah Chittenden, Ana M. Denis-Bacelar et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2017 · 78 citations · Full text

Medicine, Nuclear Medicine, Radiology +16